Duration of complete remission (CR) in different risk groups according to CRACdep
| Treatment groups . | No. total . | No. censored . | No. of events (=relapse) . | Duration of CR, mo . | SE . | CI . | P . |
|---|---|---|---|---|---|---|---|
| All | |||||||
| CRACdep positive | 35 | 27 | 8 | 68.5 | 5.4 | 58.8-79.1 | .001 |
| CRACdep negative | 5 | 1 | 4 | 11.4 | 2.2 | 7.1-15.7 | — |
| SR | |||||||
| CRACdep positive | 10 | 9 | 1 | 78.7 | 6.9 | 65.3-92.2 | — |
| CRACdep negative | — | — | — | — | — | — | — |
| HR | |||||||
| CRACdep positive | 24 | 17 | 7 | 62.6 | 7.1 | 48.7-76.6 | .014 |
| CRACdep negative | 5 | 1 | 4 | 11.4 | 2.2 | 7.1-15.7 | — |
| Treatment groups . | No. total . | No. censored . | No. of events (=relapse) . | Duration of CR, mo . | SE . | CI . | P . |
|---|---|---|---|---|---|---|---|
| All | |||||||
| CRACdep positive | 35 | 27 | 8 | 68.5 | 5.4 | 58.8-79.1 | .001 |
| CRACdep negative | 5 | 1 | 4 | 11.4 | 2.2 | 7.1-15.7 | — |
| SR | |||||||
| CRACdep positive | 10 | 9 | 1 | 78.7 | 6.9 | 65.3-92.2 | — |
| CRACdep negative | — | — | — | — | — | — | — |
| HR | |||||||
| CRACdep positive | 24 | 17 | 7 | 62.6 | 7.1 | 48.7-76.6 | .014 |
| CRACdep negative | 5 | 1 | 4 | 11.4 | 2.2 | 7.1-15.7 | — |
Risk group assignment was not available for one patient (CRACdep positive and no relapse) in these analyses.
P indicates significance by log rank test; and —, not applicable.